Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
690 participants
INTERVENTIONAL
2006-10-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Evaluation of A Mailed Arthritis Self-Management Program
NCT00448474
Patient Education in Rheumatoid Arthritis and Osteoarthritis
NCT00000414
Self-Directed Exercise Program for Adults With Arthritis
NCT01172327
Evaluation of the Active Living Every Day Exercise Program for People With Arthritis
NCT00146367
Activity, Rheumatoid and Osteoarthritis, and Weight Management
NCT00365404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arthritis self-management workshop
Comparison of two-week, lay led, scripted self-management workshop emphasizing action planning, problem-solving, and content specific to arthritis.
Arthritis Quick Start
Two week, lay led, workshop focusing on goal setting, problem solving, and content specific to disease management.
Delayed treatment intervention
After four months delay, participants in Control Group receive Experimental workshop.
Delayed treatment control
After 4 month delay, participants in Control Group receive Experimental intervention.
Delayed treatment intervention
After four months delay, participants in Control Group receive Experimental workshop.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arthritis Quick Start
Two week, lay led, workshop focusing on goal setting, problem solving, and content specific to disease management.
Delayed treatment intervention
After four months delay, participants in Control Group receive Experimental workshop.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Arthritis diagnosis
* No prior participation in arthritis self-management
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Centers for Disease Control and Prevention
FED
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UNC-Chapel Hill
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Goeppinger, PhD, BSN
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Kate Lorig, DrPH, BSN
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University Patient Education Research Center
Palo Alto, California, United States
University of North Carolina Center for Health Promotion & Disease Prevention
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S3521-24/24
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
06-0398-1-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.